Version October 2024
Skin irritation: Note: Approved ages in pediatric patients may vary among products, consult product specific labeling.
Calamine/zinc oxide products: Infants ≥6 months, Children, and Adolescents: Topical: Apply to affected area as often as needed; other calamine products are used up to 3 to 4 times daily
Calamine/pramoxine products: Children ≥2 years and Adolescents: Topical: Apply to affected area up to 3 to 4 times daily
(For additional information see "Calamine lotion: Drug information")
Skin irritation: Topical: Apply to affected area as often as needed (zinc oxide–containing products) or up to 3 to 4 times daily (pramoxine-containing products).
There are no adverse reactions listed in the manufacturer's labeling.
Other warnings/precautions:
• Self-medication (OTC use): For external use only; avoid contact with eyes and mucous membranes. Discontinue use and contact healthcare provider if needed for >7 days or if condition worsens.
Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, >3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Shehab 2009).
Excipient information presented when available (limited, particularly for generics); consult specific product labeling.
Lotion, External:
Caladryl: Calamine 8% and pramoxine hydrochloride 1% (177 mL) [contains methylparaben, polysorbate 80, propylene glycol, propylparaben]
Calagesic: Calamine 8% and pramoxine hydrochloride 1% (177 mL) [contains alcohol, usp, methylparaben, polysorbate 80, propylene glycol, propylparaben]
GoodSense Medicated Calamine: Calamine 8% and pramoxine hydrochloride 1% (177 mL) [contains alcohol, usp, methylparaben, polysorbate 80, propylene glycol, propylparaben]
Generic: 8% (177 mL)
Suspension, External:
GoodSense Calamine: Calamine 8% and zinc oxide 8% (177 mL)
Yes
Lotion (Caladryl External)
1-8% (per mL): $0.03
Lotion (Calagesic External)
1-8% (per mL): $0.03
Disclaimer: A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer. Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions. In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data. Pricing data is updated monthly.
Topical: Shake well before using. Apply to clean, dry skin; may apply using cotton or a soft cloth. Avoid contact with the eyes and mucous membranes; do not use on open wounds or burns.
Shake well prior to use. Apply to clean, dry skin; avoid contact with eyes and mucous membranes; do not use on open wounds or burns.
Store at controlled room temperature.
Temporary relief of pain and itching associated with rashes due to poison ivy, poison oak, or poison sumac; insect bites; minor skin irritation; or minor cuts and to dry oozing and weeping of poison ivy, poison oak, and poison sumac (in combination with zinc oxide: FDA approved in ages ≥6 months and adults; in combination with pramoxine: FDA approved in ages ≥2 years and adults); has also been used for skin irritation and itching due to varicella (chicken pox) infection. Note: Approved ages in pediatric patients may vary among products, consult product specific labeling.
None known.
Note: Interacting drugs may not be individually listed below if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed). For a complete list of drug interactions by individual drug name and detailed management recommendations, use the drug interactions program
There are no known significant interactions.
Do you want to add Medilib to your home screen?
